Alimta® Alone or with Platinol® Benefits Patients with Recurrent Mesothelioma
According to results recently published in the Journal of Thoracic Oncology, treatment with the chemotherapy agent Alimta® (pemetrexed) with or without the chemotherapy agent Platinol® (cisplatin) provides benefit for patients with malignant mesothelioma who have received prior therapies.
This entry was posted on Friday, August 4th, 2006 at 8:06 am and is filed under Research, Treatment, Mesothelioma. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.